These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36346149)

  • 1. Novel plasma and brain proteins that are implicated in multiple sclerosis.
    Lin X; Yang Y; Gresle M; Cuellar-Partida G; Han X; Stankovich J; ; Simpson-Yap S; Fuh-Ngwa V; Charlesworth J; Burdon KP; Butzkueven H; Taylor BV; Zhou Y
    Brain; 2023 Jun; 146(6):2464-2475. PubMed ID: 36346149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome.
    Sun J; Zhao J; Jiang F; Wang L; Xiao Q; Han F; Chen J; Yuan S; Wei J; Larsson SC; Zhang H; Dunlop MG; Farrington SM; Ding K; Theodoratou E; Li X
    Genome Med; 2023 Sep; 15(1):75. PubMed ID: 37726845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma proteomic profiles of UK Biobank participants with multiple sclerosis.
    Jacobs BM; Vickaryous N; Giovannoni G; Proitsi P; Waters S; Dobson R
    Ann Clin Transl Neurol; 2024 Mar; 11(3):698-709. PubMed ID: 38282238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating genomics and proteomics data to identify candidate plasma biomarkers for lung cancer risk among European descendants.
    Yang Y; Xu S; Jia G; Yuan F; Ping J; Guo X; Tao R; Shu XO; Zheng W; Long J; Cai Q
    Br J Cancer; 2023 Oct; 129(9):1510-1515. PubMed ID: 37679517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis: genetics, biomarkers, treatments.
    Axisa PP; Hafler DA
    Curr Opin Neurol; 2016 Jun; 29(3):345-53. PubMed ID: 27058221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prioritizing Candidates of Post-Myocardial Infarction Heart Failure Using Plasma Proteomics and Single-Cell Transcriptomics.
    Chan MY; Efthymios M; Tan SH; Pickering JW; Troughton R; Pemberton C; Ho HH; Prabath JF; Drum CL; Ling LH; Soo WM; Chai SC; Fong A; Oon YY; Loh JP; Lee CH; Foo RSY; Ackers-Johnson MA; Pilbrow A; Richards AM
    Circulation; 2020 Oct; 142(15):1408-1421. PubMed ID: 32885678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining evidence from four immune cell types identifies DNA methylation patterns that implicate functionally distinct pathways during Multiple Sclerosis progression.
    Ewing E; Kular L; Fernandes SJ; Karathanasis N; Lagani V; Ruhrmann S; Tsamardinos I; Tegner J; Piehl F; Gomez-Cabrero D; Jagodic M
    EBioMedicine; 2019 May; 43():411-423. PubMed ID: 31053557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
    Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
    Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capturing SNP Association across the NK Receptor and HLA Gene Regions in Multiple Sclerosis by Targeted Penalised Regression Models.
    Burnard SM; Lea RA; Benton M; Eccles D; Kennedy DW; Lechner-Scott J; Scott RJ
    Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial vezatin and its association with endometriosis risk.
    Holdsworth-Carson SJ; Fung JN; Luong HT; Sapkota Y; Bowdler LM; Wallace L; Teh WT; Powell JE; Girling JE; Healey M; Montgomery GW; Rogers PA
    Hum Reprod; 2016 May; 31(5):999-1013. PubMed ID: 27005890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genome-wide association study of brain lesion distribution in multiple sclerosis.
    Gourraud PA; Sdika M; Khankhanian P; Henry RG; Beheshtian A; Matthews PM; Hauser SL; Oksenberg JR; Pelletier D; Baranzini SE
    Brain; 2013 Apr; 136(Pt 4):1012-24. PubMed ID: 23412934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans.
    Shams H; Shao X; Santaniello A; Kirkish G; Harroud A; Ma Q; Isobe N; ; Schaefer CA; McCauley JL; Cree BAC; Didonna A; Baranzini SE; Patsopoulos NA; Hauser SL; Barcellos LF; Henry RG; Oksenberg JR
    Brain; 2023 Feb; 146(2):645-656. PubMed ID: 35253861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Sclerosis Biomarker Candidates Revealed by Cell-Type-Specific Interactome Analysis.
    Yurduseven K; Babal YK; Celik E; Kerman BE; Kurnaz IA
    OMICS; 2022 May; 26(5):305-317. PubMed ID: 35483054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying causal genes for depression via integration of the proteome and transcriptome from brain and blood.
    Deng YT; Ou YN; Wu BS; Yang YX; Jiang Y; Huang YY; Liu Y; Tan L; Dong Q; Suckling J; Li F; Yu JT
    Mol Psychiatry; 2022 Jun; 27(6):2849-2857. PubMed ID: 35296807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale integration of the plasma proteome with genetics and disease.
    Ferkingstad E; Sulem P; Atlason BA; Sveinbjornsson G; Magnusson MI; Styrmisdottir EL; Gunnarsdottir K; Helgason A; Oddsson A; Halldorsson BV; Jensson BO; Zink F; Halldorsson GH; Masson G; Arnadottir GA; Katrinardottir H; Juliusson K; Magnusson MK; Magnusson OT; Fridriksdottir R; Saevarsdottir S; Gudjonsson SA; Stacey SN; Rognvaldsson S; Eiriksdottir T; Olafsdottir TA; Steinthorsdottir V; Tragante V; Ulfarsson MO; Stefansson H; Jonsdottir I; Holm H; Rafnar T; Melsted P; Saemundsdottir J; Norddahl GL; Lund SH; Gudbjartsson DF; Thorsteinsdottir U; Stefansson K
    Nat Genet; 2021 Dec; 53(12):1712-1721. PubMed ID: 34857953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide DNA methylation profiles indicate CD8+ T cell hypermethylation in multiple sclerosis.
    Bos SD; Page CM; Andreassen BK; Elboudwarej E; Gustavsen MW; Briggs F; Quach H; Leikfoss IS; Bjølgerud A; Berge T; Harbo HF; Barcellos LF
    PLoS One; 2015; 10(3):e0117403. PubMed ID: 25734800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare variant associations with plasma protein levels in the UK Biobank.
    Dhindsa RS; Burren OS; Sun BB; Prins BP; Matelska D; Wheeler E; Mitchell J; Oerton E; Hristova VA; Smith KR; Carss K; Wasilewski S; Harper AR; Paul DS; Fabre MA; Runz H; Viollet C; Challis B; Platt A; ; Vitsios D; Ashley EA; Whelan CD; Pangalos MN; Wang Q; Petrovski S
    Nature; 2023 Oct; 622(7982):339-347. PubMed ID: 37794183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci.
    International Multiple Sclerosis Genetics Consortium (IMSGC)
    Hum Mol Genet; 2010 Mar; 19(5):953-62. PubMed ID: 20007504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic associations with brain cortical thickness in multiple sclerosis.
    Matsushita T; Madireddy L; Sprenger T; Khankhanian P; Magon S; Naegelin Y; Caverzasi E; Lindberg RL; Kappos L; Hauser SL; Oksenberg JR; Henry R; Pelletier D; Baranzini SE
    Genes Brain Behav; 2015 Feb; 14(2):217-27. PubMed ID: 25684059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.